Cargando…
Prognosis of limited-stage small cell lung cancer with comprehensive treatment including radical resection
BACKGROUND: The NCCN (National Comprehensive Cancer Network) Clinical Practice Guidelines in Oncology (NCCN guidelines) recommend radical resection for T1-2N0M0 patients with limited-stage small cell lung cancer (LS-SCLC). However, only about 5% of patients with small cell cancer (SCLC) were initial...
Autores principales: | Zhong, Lili, Suo, Jiaojiao, Wang, Ya, Han, Jialong, Zhou, Huijie, Wei, Hao, Zhu, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998207/ https://www.ncbi.nlm.nih.gov/pubmed/32013993 http://dx.doi.org/10.1186/s12957-020-1807-1 |
Ejemplares similares
-
PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer
por: Fu, Xiao, et al.
Publicado: (2020) -
Adjuvant therapies for resected limited-stage small cell lung cancer
por: Lampridis, Savvas
Publicado: (2021) -
Comprehensive analysis of prognostic predictors for patients with limited-stage small-cell lung cancer who underwent resection followed by adjuvant chemotherapy
por: Feng, Jian, et al.
Publicado: (2021) -
T790M mutation in stage IV EGFR-mutated NSCLC patient with acquired resistance reverted to original 19Del mutation after administration of a series of precision treatments: a case report
por: Han, Jialong, et al.
Publicado: (2018) -
Impact of Adjuvant Therapy on Survival in Surgically Resected Limited-Stage Small Cell Lung Cancer
por: Li, Di, et al.
Publicado: (2021)